Cloned (Comment) | Organism |
---|---|
expression in HEK293 cells | Mus musculus |
Protein Variants | Comment | Organism |
---|---|---|
N146A | mutation results in the decreased zymogen activation of proPC1/3 and virtually inhibits its secretion | Mus musculus |
N374A | mutant is processed and secreted at nearly the same rate and with the same apparent molecular mass as wild-type. Residue N374 does not appear to bear an N-glycan | Mus musculus |
N618A | mutation does not significantly affect zymogen activation | Mus musculus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(3S,4S,5S,6R)-2-([(2R,3S,4S,5S,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-methoxytetrahydro-2H-pyran-4-yl]amino)-6-(hydroxymethyl)tetrahydro-2H-thiopyran-3,4,5-triol | i.e. BJ-12-26-1, greatly reduces the processing of substrate proopiomelanocortin | Mus musculus | |
(3S,4S,5S,6R)-2-([(2S,3S,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3-yl]amino)-6-(hydroxymethyl)tetrahydro-2H-thiopyran-3,4,5-triol | i.e. BJ-12-21-2, greatly reduces the processing of substrate proopiomelanocortin | Mus musculus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | - |
- |
- |
Posttranslational Modification | Comment | Organism |
---|---|---|
glycoprotein | mutation of N-glycosylation site N146 results in the decreased zymogen activation of proPC1/3 and virtually inhibits its secretion. Mutation of glycosylation site N618A mutation does not significantly affect zymogen activation. The presence, but not the exact structure, of N-glycans is crucial for proPC1/3 zymogen processing | Mus musculus |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
proopiomelanocortin + H2O | - |
Mus musculus | beta-lipotropic hormone + adrenocorticotropic hormone + ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
PC1/3 | - |
Mus musculus |